FDA

12 stories · 3 sources · updated every week

The FDA is currently investigating a Cyclospora outbreak linked to Taylor Farms, with inspections underway at Mexican farms. Meanwhile, the agency faces scrutiny over Zyn's approval and a looming July 23-24 vote on peptide compounding, all while awaiting a new Commissioner.

FDA

Timeline

FDA Sticks With Taylor Farms After Cyclospora False Positive

FDA Finds Cyclospora in Taylor Farms Lettuce

FDA to Inspect Mexican Farms in Cyclospora Probe

CDC: Taco Bell Lettuce Source of Cyclospora Outbreak

FDA Approves Merck's Lipfendra Cholesterol Pill

Kalshi Enters Biotech; Biogen Alzheimer's Drug in Question

Kalshi launches bets on clinical trials, FDA approvals

Venom-Derived Drugs: From Captopril to Ozempic

Deaths from coronary artery disease have fallen, but more progress is within reach

Opinion: Why we still don’t know what foods are the source of the cyclospora outbreak

An Inventor of Apple's FaceID Wants to Analyze Your Brain's Health With AI

FDA CBER acting director Mikhail pledges normalcy to staff

XR Health acquires Swing Therapeutics for fibromyalgia app

FDA Approved Zyn Pouches Without Knowing What They’re Made Of

FDA OKs First Wearable Cancer Drug; RFK Targets SSRIs

Reed Jobs would rather talk about curing cancer than his last name

White House Reviews FDA Commissioner Finalists

STAT+: The quest to save Grace — and clear the way for rare disease patients everywhere

Semaglutide Dosing Errors Fueled Poison Call Spike

STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more

Shows up with